Bupropion hydrochloride produces conditioned hyperactivity in rats

Barrickman, 1995, Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 34, 649, 10.1097/00004583-199505000-00017 Cyr, 1998, Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder, Drugs, 56, 215, 10.2165/00003495-199856020-00005 Ascher, 1995, Bupropion: a review of its mechanism of antidepressant activity, J Clin Psychiatry, 56, 395 Ferris, 1983, Studies of bupropions mechanism of antidepressant activity, J Clin Pschychiaty, 44, 74 Fryer, 1999, Noncompetitive functional inhibition at diverse human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine, J Pharmacol Exp Ther, 288, 88 Damaj, 2004, Enantioselective effects of metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors, Mol Pharmacol, 66, 675, 10.1124/mol.104.001313 Miller, 2002, Bupropion inhibits nicotine-evoked [(3)H] overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine, J Pharmacol Exp Ther, 302, 1113, 10.1124/jpet.102.033852 Slemmer, 2000, Bupropion is a nicotinic antagonist, J Pharmacol Exp Ther, 295, 321 Cooper, 1980, Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo, J Pharmacol Exp Ther, 215, 127 Nomikos, 1992, Effect of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum, Neuropsychopharmacology, 7, 7 Ortmann, 1985, The conditioned place preference paradigm in rats: effect of bupropion, Life Sci, 37, 2021, 10.1016/0024-3205(85)90033-5 Wilkinson, 2006, Pre-exposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats, Nicotine Tob Res, 8, 141, 10.1080/14622200500484642 Nielsen, 1986, Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons, Pharmacol Biochem Behav, 24, 795, 10.1016/0091-3057(86)90413-2 Bevins, 2001, Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression, Pharmacol Biochem Behav, 68, 135, 10.1016/S0091-3057(00)00451-2 Bevins, 2004, Individual differences in rats' reactivity to novelty and the unconditioned and conditioned locomotor effects of methamphetamine, Pharmacol Biochem Behavior, 79, 65, 10.1016/j.pbb.2004.06.002 Stewart, 1992, Conditioned stimulus control of the expression of sensitization of the behavioral activating effects of opiate and stimulant drugs, 129 Wise, 1993, Psychomotor-stimulant sensitization: a unitary phenomenon?, Behav Pharmacol, 4, 339, 10.1097/00008877-199308000-00007 Lamb, 1990, Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine, Psychopharmacology, 102, 183, 10.1007/BF02245920 Tella, 1997, Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine, J Pharmacol Exp Ther, 281, 508 Piazza, 1989, Factors that predict individual vulnerability to amphetamine self-administration, Science, 245, 1511, 10.1126/science.2781295 Deroche, 1993, Individual differences in psychomotor effects of morphine are predicted by reactivity to novelty and influenced by corticosterone secretion, Brain Res, 623, 341, 10.1016/0006-8993(93)91451-W Gringas, 1996, Analysis of the biphasic locomotor response to ethanol in high and low responders to novelty: a study in Nijmegen Wistar rats, Psychopharmacology, 125, 258, 10.1007/BF02247337 Hooks, 1992, Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions, Pharmacol Biochem Behav, 43, 815, 10.1016/0091-3057(92)90413-A Jodogne, 1994, Animals predisposed to develop amphetamine self-administration show higher susceptibility to develop contextual conditioning of both amphetamine-induced hyperlocomotion and sensitization, Brain Res, 657, 236, 10.1016/0006-8993(94)90973-3 Kalinichev, 2004, Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization, Psychopharmacology, 177, 61, 10.1007/s00213-004-1990-8 Dellu, 1996, Behavioral reactivity to novelty during youth as a predictive factor of stress-induced corticosterone secretion in the elderly—a life-span study in rats, Psychoneuroendocrinology, 21, 441, 10.1016/0306-4530(96)00017-0 Piazza, 1996, Pathophysiological basis of vulnerability to drug abuse: role of and interaction between stress, glucocorticoids, and dopaminergic neurons, Ann Rev Pharmacol Toxicol, 36, 359, 10.1146/annurev.pa.36.040196.002043 Bardo, 1996, Psychobiology of novelty seeking and drug seeking behavior, Behav Brain Res, 77, 23, 10.1016/0166-4328(95)00203-0 Bevins, 2001, Novelty seeking and reward: implications for the study of high-risk behaviors, Curr Dir Psychol Sci, 10, 189, 10.1111/1467-8721.00146 Klebaur, 2001, Individual differences in behavioral responses to novelty and amphetamine self-administration in female and male rats, Behav Pharmacol, 12, 267, 10.1097/00008877-200107000-00005 Besheer, 2004, Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats, Psychopharmacology, 172, 108, 10.1007/s00213-003-1621-9 Cryan, 2003, Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat, Psychopharmacology, 168, 347, 10.1007/s00213-003-1445-7 Jones, 1980, Stimulus properties of antidepressants in the rat, Psychopharmacology, 67, 111, 10.1007/BF00431964 Bevins, 2002, Novel-object place conditioning: behavioral and dopaminergic processes in expression of novelty reward, Behav Brain Res, 129, 41, 10.1016/S0166-4328(01)00326-6 Adams, 2000, Conditioned locomotor stimulant effects of cocaine in rats do not result from interference with habituation, Psychopharmacology, 151, 13, 10.1007/s002130000431 Barr, 1983, Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy, Life Sci, 33, 1341, 10.1016/0024-3205(83)90817-2 Carey, 1994, Conditioned cocaine induced hyperactivity: an association with increased medial prefrontal cortex serotonin, Behav Brain Res, 62, 177, 10.1016/0166-4328(94)90026-4 Mazurski, 1991, Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats, Psychopharmacology, 105, 107, 10.1007/BF02316871 Duvauchelle, 2000, Conditioned increases in behavioral activity and accumbens dopamine levels produces by IV cocaine, Behav Neurosci, 114, 1156, 10.1037/0735-7044.114.6.1156 Gold, 1988, The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine, Behav Neurosci, 102, 544, 10.1037/0735-7044.102.4.544 Exner, 1993, Behaviour in the novel environment predicts responsiveness to d-amphetamine in the rat: a multivariate approach, Behav Pharmacol, 4, 47, 10.1097/00008877-199302000-00005 Hooks, 1991, Individual differences in amphetamine sensitization: dose-dependent effects, Pharmacol Biochem Behav, 41, 203, 10.1016/0091-3057(92)90083-R Piazza, 1991, Corticosterone levels determine individual vulnerability to amphetamine self-administration, Proc Natl Acad Sci USA, 88, 2088, 10.1073/pnas.88.6.2088 Knych, 1979, Effect of amphetamine on plasma corticosterone in the conscious rat, Neuroendocrinolgy, 29, 110, 10.1159/000122912 Moldow, 1987, Cocaine induced secretion of ATCH, beta-endorphin, and corticosterone, Peptide, 8, 819, 10.1016/0196-9781(87)90065-9 Szumiinski, 2001, Iboga compounds reverse the behavioral disinhibiting and corticosterone effects of acute methamphetamine: implications for their antiaddictive properties, Pharmacol Biochem Behav, 69, 485, 10.1016/S0091-3057(01)00564-0 Piancentini, 2003, Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat, J Appl Physiol, 95, 652, 10.1152/japplphysiol.01058.2002